Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400084512Phase 4Recruiting
Phase 4 trial of tramadol, sufentanil and propofol in None (2 arms), sponsored by Xianyang First People's Hospital. Primary endpoint: Anesthetic effect. Started May 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400084512.